Coagulation and Platelet Function during and after Adult Liver Transplantation with ROTEM
Not Applicable
Completed
- Conditions
- Digestive SystemEnd-stage liver disease patients scheduled for liver transplantation
- Registration Number
- PACTR201803003217132
- Lead Sponsor
- ational liver institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
End stage liver disease scheduled for adult liver transplantation.
Exclusion Criteria
Patients on preoperative oral anticoagulant, antiplatelets.
Patients on any drugs affecting platelets function and count or causing pancytopenia e.g Impenam, Diflucan.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method